Determinants of iron accumulation in deep grey matter of multiple sclerosis patients

Stefan Ropele, Iris D Kilsdonk, Mike P Wattjes, Christian Langkammer, Wolter L de Graaf, Jette L Frederiksen, Henrik B Larsson, Marios Yiannakas, Claudia Am Wheeler-Kingshott, Christian Enzinger, Michael Khalil, Maria A Rocca, Till Sprenger, Michael Amann, Ludwig Kappos, Massimo Filippi, Alex Rovira, Olga Ciccarelli, Frederik Barkhof, Franz Fazekas

38 Citations (Scopus)

Abstract

BACKGROUND: Iron accumulation in deep grey matter (GM) structures is a consistent finding in multiple sclerosis (MS) patients. This study focused on the identification of independent determinants of iron accumulation using R2* mapping.

SUBJECTS AND METHODS: Ninety-seven MS patients and 81 healthy controls were included in this multicentre study. R2* mapping was performed on 3T MRI systems. R2*in deep GM was corrected for age and was related to disease duration, disability, T2 lesion load and brain volume.

RESULTS: Compared to controls, R2* was increased in all deep GM regions of MS patients except the globus pallidus and the substantia nigra. R2* increase was most pronounced in the progressive stage of the disease and independently predicted by disease duration and disability. Reduced cortical volume was not associated with iron accumulation in the deep GM with the exception of the substantia nigra and the red nucleus. In lesions, R2* was inversely correlated with disease duration and higher total lesion load.

CONCLUSION: Iron accumulation in deep GM of MS patients is most strongly and independently associated with duration and severity of the disease. Additional associations between cortical GM atrophy and deep GM iron accumulation appear to exist in a region specific manner.

Original languageEnglish
JournalMultiple Sclerosis
Volume20
Issue number13
Pages (from-to)1692-1698
Number of pages7
ISSN1352-4585
DOIs
Publication statusPublished - 20 Nov 2014

Fingerprint

Dive into the research topics of 'Determinants of iron accumulation in deep grey matter of multiple sclerosis patients'. Together they form a unique fingerprint.

Cite this